Co-delivery of doxorubicin hydrochloride and verapamil hydrochloride by pH-sensitive polymersomes for the reversal of multidrug resistance-Reference-Cited by-同舟云学术

Co-delivery of doxorubicin hydrochloride and verapamil hydrochloride by pH-sensitive polymersomes for the reversal of multidrug resistance

Published:2015 Issue:95 Volume:5 Page:77986-77995
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Li Nuannuan¹²³⁴,Zhang Pei¹²³⁴,Huang Chunzhi¹²³⁴,Song Yunmei⁵⁶⁷⁸,Garg Sanjay⁵⁶⁷⁸,Luan Yuxia¹²³⁴

Affiliation:

1. School of Pharmaceutical Science

2. Shandong University

3. Jinan

4. P. R. China

5. School of Pharmacy and Medical Sciences

6. University of South Australia

7. Adelaide

8. Australia

Abstract

A promising co-delivery system was proposed for effectively reversing multidrug resistance of cancer cells and simultaneously improving the anticancer effect of the drug.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2015/RA/C5RA15313A

Reference44 articles.

1. Doxorubicin-Induced Cardiomyopathy

2. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(γ-benzyl l-glutamate)-b-hyaluronan polymersomes

3. Targeting multidrug resistance in cancer

4. Gold-doxorubicin nanoconjugates for overcoming multidrug resistance

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid-based nanoparticle-mediated combination therapy for breast cancer management: a comprehensive review;Drug Delivery and Translational Research;2023-06-01

2. Design and Synthesis of Amphiphilic Graft Polyphosphazene Micelles for Docetaxel Delivery;Pharmaceutics;2023-05-22

3. Recent Advances in Nanoparticle-Based Co-Delivery Systems for Cancer Therapy;Nanomaterials;2022-08-04

4. Nanovesicles for drug codelivery;Applications of Nanovesicular Drug Delivery;2022

5. Multifunctional Polymeric Nanoparticles in Targeted and Controlled Delivery for Cancer Therapy;Nanoengineering of Biomaterials;2021-12-10